Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Leiomyosarcoma × PM 01183 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 7 Sarcoma, Ewing 2 Neoplasms 2 Lung Neoplasms 2 Desmoplastic Small Round Cell Tumor 2 Sarcoma 1 Ovarian Neoplasms 1 Neutropenia 1 Leiomyosarcoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 4 Trabectedin 2 Specimen Handling 2 Doxorubicin 2 regorafenib 1 liposomal doxorubicin 1 abemaciclib 1 Tissue Banks 1 Surgical Procedures, Operative 1 Standard of Care 1 Radiotherapy 1 Quality of Life 1 PM 01183 1 Neoadjuvant Therapy 1 Docetaxel 1 Dacarbazine 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06088290 2026-03-11

SaLuDo

PharmaMar

Phase 3 Recruiting

Leiomyosarcoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡